IsomAb appoints Dr Philip Brainin as Chief Executive Officer
Nottingham, UK, March 19 – IsomAb Ltd, a UK-based biotechnology company, today announced the appointment of Dr Philip Brainin as Chief Executive Officer (CEO) and member of the Board of Directors. IsomAb is developing transformative isoform‑specific…